0001213900-21-012343.txt : 20210301
0001213900-21-012343.hdr.sgml : 20210301
20210301061318
ACCESSION NUMBER: 0001213900-21-012343
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20210224
FILED AS OF DATE: 20210301
DATE AS OF CHANGE: 20210301
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Pankovcin Corinne
CENTRAL INDEX KEY: 0001527535
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-39336
FILM NUMBER: 21693604
MAIL ADDRESS:
STREET 1: BUSINESS DEVELOPMENT CORP OF AMERICA
STREET 2: 405 PARK AVENUE, 14TH FLOOR
CITY: NEW YORK
STATE: NY
ZIP: 10022
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Aditx Therapeutics, Inc.
CENTRAL INDEX KEY: 0001726711
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 823204328
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 2569 WYANDOTTE, ST.
STREET 2: SUITE 101
CITY: MOUNTAIN
STATE: CA
ZIP: 94043
BUSINESS PHONE: 909-488-0844
MAIL ADDRESS:
STREET 1: 2569 WYANDOTTE, ST.
STREET 2: SUITE 101
CITY: MOUNTAIN
STATE: CA
ZIP: 94043
FORMER COMPANY:
FORMER CONFORMED NAME: ADiTx Therapeutics, Inc.
DATE OF NAME CHANGE: 20171229
4
1
ownership.xml
X0306
4
2021-02-24
0
0001726711
Aditx Therapeutics, Inc.
ADTX
0001527535
Pankovcin Corinne
C/O ADITX THERAPEUTICS, INC.
2569 WYANDOTTE ST., SUITE 101
MOUNTAIN VIEW
CA
94043
0
1
0
0
CHIEF FINANCIAL OFFICER
Common Stock
2021-02-24
4
A
0
110000
0
A
110000
D
The restricted common stock shall vest in three (3) successive equal annual installments, beginning on March 31, 2021.
/s/ Corinne Pankovcin
2021-03-01